Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
Duke University HospitalResidency, 2008 - 2011
University of Alabama School of MedicineClass of 2008
Certifications & Licensure
TN State Medical License 2012 - 2026
AL State Medical License 2020 - 2020
NC State Medical License 2008 - 2011- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.Rachel Woodford, Janet McKeown, Lotte L Hoeijmakers, Johanna Mangana, Florentia Dimitriou
European Journal of Cancer. 2024-11-01 - Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma.Kylie Fletcher, Saba Rehman, Rebecca Irlmeier, Fei Ye, Douglas Johnson
The Oncologist. 2024-08-27 - 1 citationsReal-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, Amin H Nassar, Elio Adib
Clinical Lymphoma, Myeloma & Leukemia. 2024-08-01
Press Mentions
Eleven Vanderbilt Scientists Among World’s “Highly Cited” ResearchersNovember 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
